Navigation Links
Studies in Mice May Offer Clues to Cleft Lip
Date:12/1/2011

THURSDAY, Dec. 1 (HealthDay News) -- The genetic repair of cleft lips in mice embryos could eventually lead to new ways to treat and prevent the birth defect in humans, U.S. researchers report.

The scientists pinpointed the role of genes for specific proteins that coordinate cellular signaling behaviors that play a major role in the development of cleft lip and palate. Working with specially engineered mice, they also reported that altering one type of molecule within a specific signaling pathway can correct cleft lip and palate.

The study was published recently in the journal Developmental Cell.

This is the first time that anyone has corrected this defect in embryos, according to study author Dr. Licia Selleri, an associate professor of cell and developmental biology at Weill Cornell Medical College in New York City.

"This is a very provocative result because it opens a completely new avenue of strategies for tissue repair," she said in a medical college news release.

While the findings hold promise, experts note that research involving animals frequently fails to lead to benefits for humans.

Children born with cleft lip and cleft palate, which are among the most common birth defects, often require multiple surgeries, speech therapy and orthodontics because of the disfigurement.

More information

The Nemours Foundation has more about cleft lip and palate.

-- Robert Preidt

SOURCE: Weill Cornell Medical College, news release, Nov. 28, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Studies of patients with cirrhosis uncover limitations in liver cancer screening
2. Surgeon studies with world-renowned oncoplastic pioneer
3. Studies explore new approaches to treating pain
4. New studies show progress, value in vaccination against deadly pneumonia
5. UH Rainbow Babies & Childrens Hospital begins studies on vitamin D to prevent heart disease
6. Studies Suggest Link Between Smog, Joint Disease
7. Gene therapy shows promise as hemophilia treatment in animal studies
8. MU studies link depression and breast cancer outcomes
9. CHEST 2011: Embargoed studies highlight new lung cancer and COPD research
10. European studies on risks of hepatocellular carcinoma
11. Trio of studies support use of PET/CT scans as prostate cancer staging tool
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies in Mice May Offer Clues to Cleft Lip
(Date:12/2/2016)... ... December 02, 2016 , ... ... Area in Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. ... scholarship funds for area students and operating support to UNCF-member institutions, including Miles ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... announces the launch of its 60-day free trial program for all of the ... make the offer a truly hassle free experience. , FlexiSpot’s unique desktop risers ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to ... Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to ... drug plan (Part D) need to make changes during this period order for their ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a ... in the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. ... their education, experience, and professional associations. , One the most frequently honored ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)... -- Sickle cell disease (SCD) is an inherited chronic ... get stuck in veins and block blood flow, which ... leading to death. Each year, approximately 300,000 people around ... them lack access to comprehensive care or effective treatment ... SCD, a pill called hydroxyurea approved more than a ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology: